RECRUITING

A Study to Improve Skeletal Muscle in Veterans With HIV

Description

The Department of Veterans Affairs is the largest single provider of medical care to people with HIV in the United States. The condition of excess lipid within and around muscle, termed myosteatosis, predisposes Veterans to physical function decline, frailty, disability, and cardiometabolic diseases such as diabetes and cardiovascular disease. In the investigators current Merit supported cohort, the investigators found that 36% of Veterans with treated HIV and obesity have "myosteatotic type obesity". Based on the investigators findings, the investigators have designed a multipronged integrated intervention that combines: 1) dietary replacement of saturated with unsaturated fats; 2) administration of L-carnitine and omega-3 fatty acid supplementation; and 3) targeted resistance exercise training.

Conditions

Study Overview

Study Details

Study overview

The Department of Veterans Affairs is the largest single provider of medical care to people with HIV in the United States. The condition of excess lipid within and around muscle, termed myosteatosis, predisposes Veterans to physical function decline, frailty, disability, and cardiometabolic diseases such as diabetes and cardiovascular disease. In the investigators current Merit supported cohort, the investigators found that 36% of Veterans with treated HIV and obesity have "myosteatotic type obesity". Based on the investigators findings, the investigators have designed a multipronged integrated intervention that combines: 1) dietary replacement of saturated with unsaturated fats; 2) administration of L-carnitine and omega-3 fatty acid supplementation; and 3) targeted resistance exercise training.

A Randomized Trial to Optimize Skeletal Muscle While Reducing Adiposity in Veterans With HIV

A Study to Improve Skeletal Muscle in Veterans With HIV

Condition
HIV
Intervention / Treatment

-

Contacts and Locations

Nashville

Tennessee Valley Healthcare System Nashville Campus, Nashville, TN, Nashville, Tennessee, United States, 37212-2637

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Veteran
  • * HIV+
  • * antiretroviral therapy = integrase strand transfer inhibitor for at least 3 months
  • * HIV-1 RNA \<50 copies/ml
  • * age = 20 yrs
  • * BMI 28-50 kg/m2
  • * unstable body weight (gain or loss \> 5% over past 3 months)
  • * diagnosed mitochondrial disorder
  • * diagnosed type 1 or type 2 diabetes
  • * use of metformin or other anti-diabetic agents for pre-diabetes
  • * hemoglobin A1c of \>6.5% at screening visit
  • * inflammatory conditions or chronic corticosteroid use
  • * stage 3 or greater kidney disease
  • * dietary or herbal supplements known to affect body weight, muscle mass, or immune function
  • * MRI incompatibility
  • * inability to perform physical function tests due to anatomical limitations
  • * contradictions to CPET such as exercise-induced ischemia or supplemental oxygen

Ages Eligible for Study

20 Years to 80 Years

Sexes Eligible for Study

MALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

VA Office of Research and Development,

Heidi J Silver, PhD, PRINCIPAL_INVESTIGATOR, Tennessee Valley Healthcare System Nashville Campus, Nashville, TN

John R Koethe, MD, PRINCIPAL_INVESTIGATOR, Tennessee Valley Healthcare System Nashville Campus, Nashville, TN

Study Record Dates

2029-06-29